How Sean McClain founded Absci at just 22 — and now leads a freshly public biotech worth nearly $2B
Absci CEO and founder Sean McClain rings the closing bell on the NASDAQ on Thursday with his team as the Vancouver, Wash.-based biotech company went public. (Absci Photo)
Biotech CEOs tend to have advanced degrees and multiple academic credentials under…
